Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.

Tanaka, Taku; Kuzuya, Teiji; Ishigami, Masatoshi; Ito, Takanori; Ishizu, Yoji; Honda, Takashi; Ishikawa, Tetsuya; Fujishiro, Mitsuhiro

Tanaka, Taku; Kuzuya, Teiji; Ishigami, Masatoshi; Ito, Takanori; Ishizu, Yoji; Honda, Takashi; Ishikawa, Tetsuya; Fujishiro, Mitsuhiro.

Afiliación

Tanaka T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kuzuya T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan, tkuzuya@med.nagoya-u.ac.jp.
Ishigami M; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ito T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ishizu Y; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Honda T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ishikawa T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Fujishiro M; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Oncology ; 98(9): 621-629, 2020.

Article en En | MEDLINE | ID: mdl-32434180

Asunto(s)

Antineoplásicos/uso terapéutico; Neoplasias de los Conductos Biliares/tratamiento farmacológico; Carcinoma Hepatocelular/tratamiento farmacológico; Neoplasias Hepáticas/tratamiento farmacológico; Sorafenib/uso terapéutico; Adulto; Anciano; Anciano de 80 o más Años; Antineoplásicos/efectos adversos; Neoplasias de los Conductos Biliares/secundario; Carcinoma Hepatocelular/patología; Femenino; Humanos; Neoplasias Hepáticas/patología; Masculino; Persona de Mediana Edad; Supervivencia sin Progresión; Estudios Retrospectivos; Sorafenib/efectos adversos; Tasa de Supervivencia

Palabras clave

Bile duct invasion; Biliary intervention; Hepatocellular carcinoma; Sorafenib

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Carcinoma Hepatocelular / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google